We are live on
!
Find out more
KCM
Kempner Capital Management Portfolio holdings
AUM
$106M
1-Year Est. Return
29.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.35%
1 Year Est. Return
+29.1%
3 Year Est. Return
+60.88%
5 Year Est. Return
+78.2%
10 Year Est. Return
+147.6%
AUM
$152M
AUM Growth
-$55K
(-0.04%)
Cap. Flow
-$4.46M
Cap. Flow
% of AUM
-2.93%
Top 10 Holdings %
Top 10 Hldgs %
49.32%
Holding
67
New
3
Increased
25
Reduced
8
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$2.13M |
| 2 |
Verizon
VZ
|
+$2.06M |
| 3 |
NOV
NOV
|
+$2.06M |
| 4 |
Cardinal Health
CAH
|
+$1.38M |
| 5 |
ExxonMobil
XOM
|
+$222K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$4.73M |
| 2 |
Boeing
BA
|
+$2.72M |
| 3 |
Allstate
ALL
|
+$1.62M |
| 4 |
Walmart Inc
WMT
|
+$1.36M |
| 5 |
General Motors
GM
|
+$991K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.93% |
| 2 | Energy | 17.43% |
| 3 | Consumer Discretionary | 13.51% |
| 4 | Healthcare | 7.16% |
| 5 | Communication Services | 6.44% |
Similar funds
RAM
SM
AFA
SHWA
TAI
MPGIG
SFG
PWM
Kempner Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Kempner Capital Management held 67 positions worth $152M, down 0.04% from $152M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Kempner Capital Management's Q3 2017 filing shows 3 new, 25 increased, 8 reduced and 4 closed positions. Its largest new stake was Cardinal Health: 19,455 shares worth $1.3M. The largest sale was Gilead Sciences, an estimated $4.73M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 33% a quarter earlier, followed by Energy and Consumer Discretionary.
- Kempner Capital Management's largest Q3 2017 buy was Cardinal Health: 19,455 shares worth $1.3M.
- Kempner Capital Management added most to Johnson Controls International in Q3 2017, an estimated $2.13M increase.
- Kempner Capital Management's biggest Q3 2017 reduction was Boeing, cutting an estimated $2.72M.
- Kempner Capital Management fully exited Gilead Sciences in Q3 2017, selling an estimated $4.73M.
- Kempner Capital Management's ten largest holdings make up 49% of its $152M portfolio in Q3 2017.
- Kempner Capital Management opened 3 new positions and closed 4 in Q3 2017.
- Kempner Capital Management's portfolio value fell 0.04% quarter-over-quarter to $152M.
Based on Kempner Capital Management's 13F filing for Q3 2017, filed 10 Oct 2017.